Search results for "PATIENT"

showing 10 items of 5265 documents

Clinical Role of CA125 in Worsening Heart Failure

2020

Abstract Objectives The aim of this study was to evaluate the association between antigen carbohydrate 125 (CA125) and the risk of 1-year clinical outcomes in patients with worsening heart failure (HF). Background CA125 is a widely available biomarker that is up-regulated in patients with acute HF and has been postulated as a useful marker of congestion and risk stratification. Methods In a large multicenter cohort of patients with worsening HF, either in-hospital or in the outpatient setting, the independent associations between CA125 and 1-year death and the composite of death/HF readmission (adjusted for outcome-specific prognostic risk score [BIOSTAT risk score]) were determined by usin…

medicine.medical_specialtyFramingham Risk Scoreendocrine system diseasesbusiness.industrymedicine.drug_class030204 cardiovascular system & hematologymedicine.diseaseTailored treatmentfemale genital diseases and pregnancy complications03 medical and health sciences0302 clinical medicineIncreased riskHeart failureInternal medicineCohortmedicineNatriuretic peptideBiomarker (medicine)In patient030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessJACC: Heart Failure
researchProduct

Intraoperative cholangiography during cholecystectomy using a biliary-nose tube: Routinely used in patients with main bile duct stones

2021

Background: Nowadays, the “gold standard” treatment for gallbladder stones is laparoscopic cholecystectomy but the risk of iatrogenic biliary duct injuries is increased compared to “open” surgery. Intraoperative cholangiography (IOC) can be useful to avoid biliary injuries but it can also be a no-safe procedure in center in which it is not routinely performed. Aim and objective: The aim of our study is to trust the efficacy of IOC in a patient with common bile duct (CBD) and gallbladder stones using a biliary-nose tube. Materials and methods: 135 patients with gallbladder and CBD stones were treated with sequential therapy and randomly divided into two groups. Laparoscopic cholecystectomy w…

medicine.medical_specialtyGallbladder stonesEndoscopic retrograde cholangiopancreatographymedicine.diagnostic_testBile ductbusiness.industrymedicine.medical_treatmentGallbladder StoneSurgerymedicine.anatomical_structureEndoscopic retrograde cholangiopancreatographymedicineSurgeryCholecystectomyIn patientTube (fluid conveyance)LaparoscopyEndoscopic sphincterotomyVideo laparoscopic cholecystectomybusinessLaparoscopyNose
researchProduct

Small bowel angiodysplasia associated with von Willebrand's disease: report of a case.

2006

The association between angiodysplasia (AD) and von Willebrand's disease (vWD) was first described by Quick in 1967. The clinical course of patients with vWD and AD is characterized by multiple admissions to hospital for gastrointestinal bleeding, necessitating transfusions of packed red cells, factor VIII, and von Willebrand factor concentrates. The therapeutic management of these patients is difficult. Both medical and endoscopic techniques have been tried, but no treatment modality has been completely successful. We describe the clinical course of a patient affected by vWD, who suffered repeated massive gastrointestinal bleeding caused by small bowel AD. Intestinal resection was the only…

medicine.medical_specialtyGastrointestinal bleedingDiseaseGastroenterologySmall BowelAngiodysplasiaVon Willebrand factorVon willebrandSurgical oncologyhemic and lymphatic diseasesInternal medicineIntestine SmallmedicineHumansAngiodysplasiabiologybusiness.industryPatient affectedvon Willebrand's disase.General MedicineMiddle Agedmedicine.diseaseSurgeryvon Willebrand Diseasesbiology.proteinSurgeryFemaleIntestinal resectionbusinessGastrointestinal HemorrhageSurgery today
researchProduct

Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management

2007

medicine.medical_specialtyGastrointestinal bleedingbusiness.industryHematologyGeneral Medicinemedicine.diseaseGastroenterologySurgeryInternal medicinemedicineVon Willebrand diseaseIn patientAngiodysplasiabusinessGenetics (clinical)Haemophilia
researchProduct

Neopterin, cellular adhesion molecules and myeolperoxidase in patients with stable and unstable angina pectoris

2011

Neopterin, cellular adhesion molecules and myeolperoxidase in patients with stable and unstable angina pectoris Recent data indicate that the serum level of neopterin, a marker of inflammation and immune modulator secreted by monocytes/macrophages, is elevated in patients with acute coronary syndrome (ACS) and seems to be a prognostic marker for major cardiovascular events. Soluble cellular adhesion molecules (sCAMs) and myeloperoxidase (MPO) levels are also related to ACS. The aim of the present study was to evaluate differences in serum levels of neopterin, sCAMs and MPO between coronary artery disease and metabolic syndrome (CAD-MetS) patients with stable and unstable angina pectoris (SA…

medicine.medical_specialtyGeneral interestSciencemetabolic syndromecellular adhesion moleculesCoronary artery diseasechemistry.chemical_compoundangina pectorisimmune system diseasesInternal medicinemedicineIn patientMultidisciplinarybiologyUnstable anginaCell adhesion moleculeQNeopterinmedicine.diseasemyeloperoxidaseneopterinchemistryMyeloperoxidasebiology.proteinCardiologyMetabolic syndromecoronary artery diseaseProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
researchProduct

Does Physical Activity Matter for the Mental Health of University Students during the COVID-19 Pandemic?

2020

Research indicates that university and college students are at higher risk of experiencing mental health problems than other populations. This study aims to examine the relationship between Physical Activity (PA) and the mental health of Ukrainian university students during the Corona Virus Disease 2019 (COVID-19) pandemic lockdown. The conventional sample consisted of 1512 students from 11 Ukrainian universities, with a mean age of 20 years (M = 20.06, SD = 3.05) and 69% of whom were female. The cross-sectional online survey was disseminated through the most popular social media channels in Ukraine (i.e., Facebook, Viber, Telegram) and included the Generalized Anxiety Disorder (GAD-7) scal…

medicine.medical_specialtyGeneralized anxiety disorderCoronavirus disease 2019 (COVID-19)Physical activitylcsh:MedicineArticle03 medical and health sciencesanxiety; depression; PHQ-9; GAD-7; physical activity (PA); undergraduates; university students0302 clinical medicinePandemicmedicine030212 general & internal medicineuniversity studentsPsychiatryphysical activity (PA)Depression (differential diagnoses)GAD-7business.industryundergraduateslcsh:RGeneral MedicinePHQ-9medicine.diseaseanxietyMental healthPatient Health QuestionnairedepressionAnxietymedicine.symptombusiness030217 neurology & neurosurgeryJournal of Clinical Medicine; Volume 9; Issue 11; Pages: 3494
researchProduct

Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

2020

Data on the prevalence of resistance-associated substitutions (RASs) and their implications for treatment with direct-acting antivirals (DAAs) are sparse in European patients with HCV genotype 4. This study investigated RASs before and after DAA failure in different genotype 4 subtypes and evaluated retreatment efficacies. Samples of 195 genotype 4-infected patients were collected in the European Resistance Database and investigated for NS3, NS5A and NS5B RASs. Retreatment efficacies in DAA failure patients were analysed retrospectively. After NS5A inhibitor (NS5Ai) failure, subtype 4r was frequent (30%) compared to DAA-naive patients (5%) and the number of NS5A RASs was significantly highe…

medicine.medical_specialtyGenotypeHepatitis C virusMedizinHCV genotype 4HepacivirusViral Nonstructural Proteinsmedicine.disease_causeGastroenterologyAntiviral AgentsVirus03 medical and health scienceschemistry.chemical_compound0302 clinical medicineResistance-associated substitutionsChronic hepatitisMembrane interactionVirologyInternal medicineGenotypeDrug Resistance ViralmedicineHumansIn patient030212 general & internal medicineTreatment FailureNS5ANS5BRetrospective Studiesddc:616Hepatologybusiness.industryHepatitis C virusvirus diseasesHepatitis C Chronicdigestive system diseasesInfectious DiseaseschemistryRetreatmentDAA failure030211 gastroenterology & hepatologybusiness
researchProduct

A Classification System for Decision-Making in the Management of Patients with Chronic Conditions

2021

Patients with chronic diseases are frequent users of healthcare services. The systematic use of stratification tools and predictive models for this group of patients can be useful for health professionals in decision-making processes. The aim of this study was to design two new classifier systems for detecting the risk of hospital admission for elderly patients with chronic conditions. In this retrospective cohort study, a set of variables related to hospital admission for patients with chronic conditions was obtained through focus groups, a health database analysis and statistical processing. To predict the probability of admission from the set of predictor variables, a logistic regression…

medicine.medical_specialtyGeography Planning and DevelopmentTJ807-830Sample (statistics)Management Monitoring Policy and LawLogistic regressionTD194-195Renewable energy sourcesolder peopleprimary careHealth caremedicineSampling (medicine)GE1-350Environmental effects of industries and plantsRenewable Energy Sustainability and the Environmentbusiness.industryrisk assessmentRetrospective cohort studydecision-makingFocus groupEnvironmental sciencesLong-term caremanagement of chronically ill patients; primary care; risk assessment; long-term care; decision-making; older people; screening; classification systemsEmergency medicinemanagement of chronically ill patientslong-term carebusinessRisk assessmentSustainability; Volume 13; Issue 23; Pages: 13176
researchProduct

Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data

2007

Progressive deposition of globotriaosylceramide results in severe complications involving the kidney, heart and brain in both hemizygous male and heterozygous female patients with Fabry disease. Analysis of renal data from FOS - the Fabry Outcome Survey - suggests that enzyme replacement therapy with agalsidase alfa can significantly improve renal function in patients with Fabry disease, at least in those with a mild decrease in glomerular filtration rate, and may also be able to slow down the natural decline in renal function in patients with a moderate reduction in glomerular filtration rate. Conclusion: Initial results from the large cohort of patients within FOS indicate that treatment …

medicine.medical_specialtyGlobotriaosylceramideUrologyRenal functionchemistry.chemical_compoundInternal medicinemedicineHumansIn patientBeneficial effectsKidneybusiness.industryGeneral MedicineEnzyme replacement therapymedicine.diseaseFabry diseaseRecombinant ProteinsIsoenzymesEndocrinologymedicine.anatomical_structurechemistryalpha-GalactosidasePediatrics Perinatology and Child HealthFabry DiseasebusinessAgalsidase alfaGlomerular Filtration RateActa Paediatrica
researchProduct

Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double-Blind, Placebo-Controlled Trials

2017

A double-blind, placebo-controlled, gluten challenge has been proposed to confirm a diagnosis of non-celiac gluten sensitivity (NCGS) in patients without celiac disease who respond to a gluten-free diet. To determine the accuracy of this approach, we analyzed data from 10 double-blind, placebo-controlled, gluten challenge trials, comprising 1312 adults. The studies varied in the duration of the challenge (ranging from 1 day to 6 weeks), daily doses for the gluten challenge (ranging from 2 g to 52 g; 3 studies administered less than 8 g/day), and composition of the placebo (gluten-free products, xylose, whey protein, rice, or corn starch containing fermentable carbohydrates). Most of the stu…

medicine.medical_specialtyGlutensGluten sensitivityPlacebodigestive systemGastroenterologyDouble blind03 medical and health sciences0302 clinical medicinegluten-free dietInternal medicineMedicineHumansIn patient030212 general & internal medicineFood scienceceliac disease; gluten-free diet; irritable bowel syndrome; wheat allergyIrritable bowel syndromechemistry.chemical_classificationirritable bowel syndromeHepatologybusiness.industryDiagnostic Tests RoutineGastroenterologynutritional and metabolic diseasesmedicine.diseaseGlutendigestive system diseaseswheat allergychemistry030211 gastroenterology & hepatologyControlled Clinical Trials as TopicFODMAPbusinessWheat allergyceliac diseaseFood Hypersensitivity
researchProduct